Publications & Presentations

Assessing the Impact of Antidepressant Use in PTSD Patients with Elevated Suicide Risk by Using Real-World Data

Novel Interventions to Address Posttraumatic Stress Disorder in Service Members and Veterans

Leveraging multi-omic data integrations and pharmacotherapy repurposing databases to identify candidate pharmacotherapies for substance use disorders

Oral Sessions: New Fentanyl Countermeasures - Anti-Fentanyl Vaccine Alone and in Combination with Buprenorphine Prevents Distribution and Antinociceptive Effects of Fentanyl

Identifying candidate pharmacotherapies for alcohol use disorder by leveraging multi-omic data integration and multiple drug repurposing databases

Mechanism and treatments from translational efforts from the DOD-PASA consortium

PPL-138 (BU10038) AS a promising treatment for PTSDlike symptoms and excessive alcohol consumption in the context of PTSD

Leveraging big data to predict adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder

Comorbid PTSD & alcohol use disorder: A proof-of-concept randomized placebo-controlled trial with buprenorphine & naltrexone combination treatment

Incorporating Novel Deep Learning Models and Multiple Social Determinants of Health Parameters to Predict Alcohol and Substance Use Disorder Risk in Post-Traumatic Stress Disorder Patients Using Electronic Medical Records

Identifying Candidate Pharmacotherapies for Opioid Use Disorder and Alcohol Use Disorder by Leveraging Multi-omic Data Integration and Multiple Drug Repurposing Databases

Effects of the non-selective opioid ligand PPL-138 on an animal model of comorbid PTSD-AUD

Facilitating Rapid Development of Medications for Substance Use Disorders and PTSD: The DoD- Pharmacotherapies for Alcohol and Substance use disorders Alliance (PASA)

Gene Correlation Networks Replication Analysis Across Studies to Identify Top Candidate Gene Targets in Opioid Use Disorder

Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases

FKBP5 Inhibitors Modulate Alcohol Drinking and Trauma-Related Behaviors in a model of Comorbid Post-Traumatic Stress and Alcohol Use Disorder

Do Participants Exhibit Evidence of Respondent Fatigue after Completion of Subjective Questionnaires Multiple Times Across a Study? Examination of Data from a Phase I Inpatient Randomized Clinical Trial

Benxtropine, an FKBP5 inhibitor, Reduces Ethanol Drinking and Stress-Associated Phenotypes in a Rat Model of Comorbid PTSD and AUD

Preclinical Testing of FKBP5 Inhibitors for Alcohol Use Disorders-PTSD Comorbidity

Effects of FEN-CRM197 conjugate vaccine + dmLT adjuvant with and without buprenorphine on fentanyl nociception in male and female Sprague Dawley rats

Pharmacodynamic Interaction Between the Glucocorticoid Receptor Antagonist, PT150, and Ethanol in Healthy Veterans and Civilians

A Phase 1 Clinical Trial to Evaluate Pharmacodynamic Interactions after Oral Coadministration of Alcohol and the Highly Selective Glucocorticoid Receptor Antagonist, PT150

Novel Trial Design to Test Kappa Opioid receptor (KOR) Antagonism in the Treatment of Comorbid PTSD and Alcohol Use Disorder

Kappa Opioid Receptor Antagonism in the Treatment of Comorbid PTSD and Heavy Alcohol Use.

It’s Time to HEAL: Help End Addiction Long-Term

Novel Strategies for the Treatment of OUD: Anti-fentanyl Vaccine

Innovative Application of the Jira Software Technology in the Clinical Trial Case Report Form Development Process

Surmounting Barriers with Targeted Solutions: Launching the Pharmacotherapies for Alcohol and Substance Abuse Consortium

Novel Trial Design to Test Kappa Opioid Receptor (KOR) Antagonism in the Treatment of Comorbid PTSD and Alcohol Use Disorder